123 results
8-K
VANI
Vivani Medical Inc
10 Oct 18
Cost Associated with Exit or Disposal Activities
5:16pm
of severance and other employee termination benefits, substantially all of which are expected to be settled in cash during the fourth quarter of 2018 … and termination benefits, that the Company anticipates will result from the restructuring plan and the expected benefits. These forward-looking
8-K
EX-10.1
VANI
Vivani Medical Inc
1 May 18
Departure of Directors or Certain Officers
6:30am
, accrued but unused vacation pay, leave or other benefits. Employee further agrees that the Severance is not compensation for Employee’s services … claims to severance or similar benefits; any claims to expenses, attorneys’ fees or other indemnities; any claims to options or other interests
8-K
EX-99.1
VANI
Vivani Medical Inc
13 Mar 19
Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results
5:12pm
is attributable to increased personnel related costs, such as salaries, benefits, outside services, travel and stock-based compensation.
General … benefits, substantially all of which were settled in cash during the fourth quarter of 2018.
Net loss in 2018 was $35.1 million, or $0.53 per share
8-K
EX-10.1
VANI
Vivani Medical Inc
21 May 20
Termination of a Material Definitive Agreement
4:12pm
facts. As of the Accelerated Expiration Date, the Parties waive any and all rights and benefits afforded by California Civil Code section 1542, which … Section 1542 and of the implications of waiving its benefits. The waiver of California Civil Code Section 1542 is an essential term of this Letter Agreement
425
VANI
Vivani Medical Inc
7 Jun 22
Business combination disclosure
4:04pm
; the ability to realize the benefits of the proposed Merger; the ability to successfully integrate NPM’s business with Company’s business or to integrate … , including the proxy statement/prospectus, provides full details of the proposed Merger and the attendant benefits and risks. This communication
8-K
EX-99.1
3iuxjbo5cr6
5 Mar 21
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
8:11am
DEFA14A
EX-99.1
5ggyg f8l4cphd9kl
5 Mar 21
Additional proxy soliciting materials
1:29pm
8-K/A
EX-99.1
jdw5q j91c02eainp3z0
5 Mar 21
Second Sight Medical Products, Inc. Receives FDA Approval for the Argus 2s Retinal Prosthesis System
1:31pm
8-K
fo4xuw54 pwuls30ek02
7 Jun 22
Other Events
4:03pm
425
EX-99.1
jxb4obznxww n7
8 Feb 22
Business combination disclosure
12:00am
425
EX-2.1
h1lxyzcx8q92d29imgi
8 Feb 22
Business combination disclosure
12:00am
8-K
EX-99.1
6fs2l teinwlxzvp
8 Feb 22
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
12:00am
8-K
vi5 jug2cw
30 Mar 20
Second Sight Announces Employee Layoffs, Intent to Wind Down Operations and Appointment of Matthew Pfeffer as Acting CEO
3:52pm
8-K
EX-2.1
c8wvfl0 xd1
8 Feb 22
Second Sight Medical Products and Nano Precision Medical Announce Merger Agreement to Create Leading Therapeutic Implant Company
12:00am
8-K
EX-99.1
c2k2o5tth1a
15 May 23
Results of Operations and Financial Condition
6:49am